Devyser Diagnostics — Investor Relations & Filings

Devyser Diagnostics develops, manufactures, and sells diagnostic kits and solutions for advanced DNA testing. The company's products are designed for use in clinical laboratories to streamline workflows and enable rapid, accurate diagnosis. Its portfolio covers complex testing areas including hereditary diseases, oncology, and post-transplant monitoring. Key offerings include Next-Generation Sequencing (NGS) and PCR-based test kits with integrated software for applications such as chimerism analysis and non-invasive prenatal testing. In addition to its kit-based business, Devyser operates genomic laboratories that provide genetic testing services to healthcare providers and biopharmaceutical companies.